Osmol Therapeutics, Inc.

Biotechnology company · New Haven, Connecticut, United States

Osmol Therapeutics, Inc. is a biotechnology company headquartered in New Haven, Connecticut, United States. Its earliest recorded incorporation is in 2016. It has reported private securities offerings to the US SEC, most recently $2.3 million sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Osmol Therapeutics at a glance

Typebiotechnology company
HeadquartersNew Haven, Connecticut, United States
Earliest incorporation on record2016
SEC CIK1694244

What does Osmol Therapeutics do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $2.3 million sold (2022).

Frequently asked questions about Osmol Therapeutics

Where is Osmol Therapeutics headquartered?

Osmol Therapeutics, Inc. is headquartered in New Haven, Connecticut, United States.

What does Osmol Therapeutics do?

Osmol Therapeutics, Inc. is a biotechnology company.

When was Osmol Therapeutics founded?

The earliest incorporation on record for Osmol Therapeutics, Inc. is in 2016, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences